Antimicrobial resistance and COVID-19: Intersections and implications
Before the coronavirus 2019 (COVID-19) pandemic began, antimicrobial resistance (AMR)
was among the top priorities for global public health. Already a complex challenge, AMR …
was among the top priorities for global public health. Already a complex challenge, AMR …
Mortality in patients admitted to intensive care with COVID‐19: an updated systematic review and meta‐analysis of observational studies
RA Armstrong, AD Kane, E Kursumovic… - …, 2021 - Wiley Online Library
The COVID‐19 pandemic continues to cause critical illness and deaths internationally. Up to
31 May 2020, mortality in patients admitted to intensive care units (ICU) with COVID‐19 was …
31 May 2020, mortality in patients admitted to intensive care units (ICU) with COVID‐19 was …
Drug repositioning: Progress and challenges in drug discovery for various diseases
Y Hua, X Dai, Y Xu, G Xing, H Liu, T Lu, Y Chen… - European Journal of …, 2022 - Elsevier
Compared with traditional de novo drug discovery, drug repurposing has become an
attractive drug discovery strategy due to its low-cost and high efficiency. Through a …
attractive drug discovery strategy due to its low-cost and high efficiency. Through a …
A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment
Many recent studies have investigated the role of either Chloroquine (CQ) or
Hydroxychloroquine (HCQ) alone or in combination with azithromycin (AZM) in the …
Hydroxychloroquine (HCQ) alone or in combination with azithromycin (AZM) in the …
Effectiveness of favipiravir in COVID-19: a live systematic review
We performed a systematic review and meta-analysis for the effectiveness of Favipiravir on
the fatality and the requirement of mechanical ventilation for the treatment of moderate to …
the fatality and the requirement of mechanical ventilation for the treatment of moderate to …
Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story
The anti-malarial drugs chloroquine (CQ) and hydroxychloroquine (HCQ) have been
suggested as promising agents against the new coronavirus SARS-CoV-2 that induces …
suggested as promising agents against the new coronavirus SARS-CoV-2 that induces …
Exploring diverse frontiers: Advancements of bioactive 4-aminoquinoline-based molecular hybrids in targeted therapeutics and beyond
Amongst heterocyclic compounds, quinoline and its derivatives are advantaged scaffolds
that appear as a significant assembly motif for developing new drug entities. Aminoquinoline …
that appear as a significant assembly motif for developing new drug entities. Aminoquinoline …
[HTML][HTML] Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China,
in December 2020 and coronavirus disease 19 (COVID-19) was later announced as …
in December 2020 and coronavirus disease 19 (COVID-19) was later announced as …
Pseudoscience and fraudulent products for COVID-19 management
As of now, the COVID-19 pandemic has become uncontrolled and is spreading widely
throughout the world. Additionally, new variants of the mutated viral variants have been …
throughout the world. Additionally, new variants of the mutated viral variants have been …
[HTML][HTML] Network bioinformatics analysis provides insight into drug repurposing for COVID-19
X Li, J Yu, Z Zhang, J Ren, AE Peluffo, W Zhang… - Medicine in Drug …, 2021 - Elsevier
The COVID-19 disease caused by the SARS-CoV-2 virus is a health crisis worldwide. While
developing novel drugs and vaccines is long, repurposing existing drugs against COVID-19 …
developing novel drugs and vaccines is long, repurposing existing drugs against COVID-19 …